Immunocell Therapy Market - Global Outlook and Forecast 2024-2031

Report ID: 1567216 | Published Date: Jan 2025 | No. of Page: 68 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
1 Introduction to Research & Analysis Reports
    1.1 Immunocell Therapy Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Immunocell Therapy Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Immunocell Therapy Overall Market Size
    2.1 Global Immunocell Therapy Market Size: 2021 VS 2028
    2.2 Global Immunocell Therapy Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Immunocell Therapy Players in Global Market
    3.2 Top Global Immunocell Therapy Companies Ranked by Revenue
    3.3 Global Immunocell Therapy Revenue by Companies
    3.4 Top 3 and Top 5 Immunocell Therapy Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Immunocell Therapy Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Immunocell Therapy Players in Global Market
        3.6.1 List of Global Tier 1 Immunocell Therapy Companies
        3.6.2 List of Global Tier 2 and Tier 3 Immunocell Therapy Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Immunocell Therapy Market Size Markets, 2021 & 2028
        4.1.2 Chimeric Antigen Receptor (CAR) T Cell Therapy
        4.1.3 Natural Killer (NK) Cell Therapy
        4.1.4 Others
    4.2 By Type - Global Immunocell Therapy Revenue & Forecasts
        4.2.1 By Type - Global Immunocell Therapy Revenue, 2017-2022
        4.2.2 By Type - Global Immunocell Therapy Revenue, 2023-2028
        4.2.3 By Type - Global Immunocell Therapy Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Immunocell Therapy Market Size, 2021 & 2028
        5.1.2 Hospitals
        5.1.3 Clinics
        5.1.4 Others
    5.2 By Application - Global Immunocell Therapy Revenue & Forecasts
        5.2.1 By Application - Global Immunocell Therapy Revenue, 2017-2022
        5.2.2 By Application - Global Immunocell Therapy Revenue, 2023-2028
        5.2.3 By Application - Global Immunocell Therapy Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Immunocell Therapy Market Size, 2021 & 2028
    6.2 By Region - Global Immunocell Therapy Revenue & Forecasts
        6.2.1 By Region - Global Immunocell Therapy Revenue, 2017-2022
        6.2.2 By Region - Global Immunocell Therapy Revenue, 2023-2028
        6.2.3 By Region - Global Immunocell Therapy Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Immunocell Therapy Revenue, 2017-2028
        6.3.2 US Immunocell Therapy Market Size, 2017-2028
        6.3.3 Canada Immunocell Therapy Market Size, 2017-2028
        6.3.4 Mexico Immunocell Therapy Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Immunocell Therapy Revenue, 2017-2028
        6.4.2 Germany Immunocell Therapy Market Size, 2017-2028
        6.4.3 France Immunocell Therapy Market Size, 2017-2028
        6.4.4 U.K. Immunocell Therapy Market Size, 2017-2028
        6.4.5 Italy Immunocell Therapy Market Size, 2017-2028
        6.4.6 Russia Immunocell Therapy Market Size, 2017-2028
        6.4.7 Nordic Countries Immunocell Therapy Market Size, 2017-2028
        6.4.8 Benelux Immunocell Therapy Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Immunocell Therapy Revenue, 2017-2028
        6.5.2 China Immunocell Therapy Market Size, 2017-2028
        6.5.3 Japan Immunocell Therapy Market Size, 2017-2028
        6.5.4 South Korea Immunocell Therapy Market Size, 2017-2028
        6.5.5 Southeast Asia Immunocell Therapy Market Size, 2017-2028
        6.5.6 India Immunocell Therapy Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Immunocell Therapy Revenue, 2017-2028
        6.6.2 Brazil Immunocell Therapy Market Size, 2017-2028
        6.6.3 Argentina Immunocell Therapy Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Immunocell Therapy Revenue, 2017-2028
        6.7.2 Turkey Immunocell Therapy Market Size, 2017-2028
        6.7.3 Israel Immunocell Therapy Market Size, 2017-2028
        6.7.4 Saudi Arabia Immunocell Therapy Market Size, 2017-2028
        6.7.5 UAE Immunocell Therapy Market Size, 2017-2028
7 Players Profiles
    7.1 Gilead Sciences
        7.1.1 Gilead Sciences Corporate Summary
        7.1.2 Gilead Sciences Business Overview
        7.1.3 Gilead Sciences Immunocell Therapy Major Product Offerings
        7.1.4 Gilead Sciences Immunocell Therapy Revenue in Global Market (2017-2022)
        7.1.5 Gilead Sciences Key News
    7.2 Novartis
        7.2.1 Novartis Corporate Summary
        7.2.2 Novartis Business Overview
        7.2.3 Novartis Immunocell Therapy Major Product Offerings
        7.2.4 Novartis Immunocell Therapy Revenue in Global Market (2017-2022)
        7.2.5 Novartis Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer
List of Tables
    Table 1. Immunocell Therapy Market Opportunities & Trends in Global Market
    Table 2. Immunocell Therapy Market Drivers in Global Market
    Table 3. Immunocell Therapy Market Restraints in Global Market
    Table 4. Key Players of Immunocell Therapy in Global Market
    Table 5. Top Immunocell Therapy Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Immunocell Therapy Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Immunocell Therapy Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Immunocell Therapy Product Type
    Table 9. List of Global Tier 1 Immunocell Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Immunocell Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Immunocell Therapy Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Immunocell Therapy Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Immunocell Therapy Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Immunocell Therapy Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Immunocell Therapy Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Immunocell Therapy Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Immunocell Therapy Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Immunocell Therapy Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Immunocell Therapy Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Immunocell Therapy Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Immunocell Therapy Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Immunocell Therapy Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Immunocell Therapy Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Immunocell Therapy Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Immunocell Therapy Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Immunocell Therapy Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Immunocell Therapy Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Immunocell Therapy Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Immunocell Therapy Revenue, (US$, Mn), 2023-2028
    Table 30. Gilead Sciences Corporate Summary
    Table 31. Gilead Sciences Immunocell Therapy Product Offerings
    Table 32. Gilead Sciences Immunocell Therapy Revenue (US$, Mn), (2017-2022)
    Table 33. Novartis Corporate Summary
    Table 34. Novartis Immunocell Therapy Product Offerings
    Table 35. Novartis Immunocell Therapy Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Immunocell Therapy Segment by Type in 2021
    Figure 2. Immunocell Therapy Segment by Application in 2021
    Figure 3. Global Immunocell Therapy Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Immunocell Therapy Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Immunocell Therapy Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Immunocell Therapy Revenue in 2021
    Figure 8. By Type - Global Immunocell Therapy Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Immunocell Therapy Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Immunocell Therapy Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Immunocell Therapy Revenue Market Share, 2017-2028
    Figure 12. US Immunocell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Immunocell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Immunocell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Immunocell Therapy Revenue Market Share, 2017-2028
    Figure 16. Germany Immunocell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 17. France Immunocell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Immunocell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Immunocell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Immunocell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Immunocell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Immunocell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Immunocell Therapy Revenue Market Share, 2017-2028
    Figure 24. China Immunocell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Immunocell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Immunocell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Immunocell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 28. India Immunocell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Immunocell Therapy Revenue Market Share, 2017-2028
    Figure 30. Brazil Immunocell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Immunocell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Immunocell Therapy Revenue Market Share, 2017-2028
    Figure 33. Turkey Immunocell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Immunocell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Immunocell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Immunocell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 37. Gilead Sciences Immunocell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Novartis Immunocell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
68
Frequently Asked Questions
Immunocell Therapy Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Immunocell Therapy Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Immunocell Therapy Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports